HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Mycosis Fungoides

Mycosis Fungoides

Mycosis fungoides is a rare type of cutaneous T-cell lymphoma, a form of non-Hodgkin lymphoma that primarily affects the skin. Cancer research has made significant strides in understanding its pathogenesis and treatment. Recent studies have focused on identifying genetic mutations and molecular pathways involved in the disease, leading to more targeted therapies. Innovative treatments such as monoclonal antibodies, histone deacetylase inhibitors, and immune checkpoint inhibitors are being explored, offering hope for improved outcomes. Additionally, advancements in early diagnosis through skin biopsies and imaging techniques are crucial for effective management. Continued research aims to uncover the underlying mechanisms of Mycosis fungoides, paving the way for personalized and less invasive treatment options, ultimately enhancing patient quality of life and survival rates.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp